Menu
Back to Journals » Drug Design, Development and Therapy » Volume 16
Review
Oral Selective Estrogen Receptor Degraders (SERDs) in Breast Cancer: Advances, Challenges, and Current Status
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,566 | Dovepress* | 9,050+ | 287 | 9,337 | |
| PubMed Central* | 4,516 | 931 | 5,447 | ||
| Totals | 13,566 | 1,218 | 14,784 | ||
| *Since 2 September 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 17 | 0 | 0 | 0 | 7 | 10 |
View citations on PubMed Central and Google Scholar